These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 10989324)

  • 1. Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications.
    Abate N
    J Diabetes Complications; 2000; 14(3):154-74. PubMed ID: 10989324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance: the link between obesity and cardiovascular disease.
    Reaven GM
    Med Clin North Am; 2011 Sep; 95(5):875-92. PubMed ID: 21855697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease.
    Sowers JR; Frohlich ED
    Med Clin North Am; 2004 Jan; 88(1):63-82. PubMed ID: 14871051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease and modifiable cardiometabolic risk factors.
    Cannon CP
    Clin Cornerstone; 2008; 9(2):24-38; discussion 39-41. PubMed ID: 19410160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinemia--how innocent a bystander?
    Zimmet PZ
    Diabetes Care; 1993 Dec; 16 Suppl 3():56-70. PubMed ID: 8299479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes, cardiovascular risk, and the link to insulin resistance.
    Stolar MW; Chilton RJ
    Clin Ther; 2003; 25 Suppl B():B4-31. PubMed ID: 14553864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
    Zimmet P; Boyko EJ; Collier GR; de Courten M
    Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease and modifiable cardiometabolic risk factors.
    Cannon CP
    Clin Cornerstone; 2007; 8(3):11-28. PubMed ID: 18452839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic Syndrome: clinical and pathophysiological basis for a rational therapeutical approach].
    Martínez R G; Alonso K R; Novik A V
    Rev Med Chil; 2009 May; 137(5):685-94. PubMed ID: 19701560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular manifestations of insulin resistance.
    Chahwala V; Arora R
    Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, insulin resistance, and cardiovascular disease.
    Reaven G; Abbasi F; McLaughlin T
    Recent Prog Horm Res; 2004; 59():207-23. PubMed ID: 14749503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deadly quartet--the insulin resistance syndrome.
    Opara JU; Levine JH
    South Med J; 1997 Dec; 90(12):1162-8. PubMed ID: 9404899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of obesity and the risk for cardiovascular disease.
    Soufi M; Sattler AM; Herzum M; Maisch B; Schaefer JR
    Herz; 2006 May; 31(3):200-6. PubMed ID: 16770555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.